SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Novavax Eligible for Royalties and $75 Million Milestone Payment

Novavax is eligible for royalties and a $75 million milestone payment on a technology transfer in mid-2027.

NVAX

Story updates

01:42:11 PM UTC
SquawkNews
NOVAVAX - ELIGIBLE FOR $225 MLN MILESTONE PAYMENT UPON U.S. LAUNCH OF COMBO VACCINE
01:42:23 PM UTC
SquawkNews
Novavax erhält 125 Millionen US-Dollar als Meilensteinzahlung aus Sanofi-Partnerschaft Novavax e

Related stories